← Open Payments lookup

SAM SIMON: Open Payments

NPI 1326769399 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$680 in 30 payments from 6 companies in 2025. Trend: 2023 $331 · 2024 $588 · 2025 $680

Food & beverage: $680
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$255
ABBVIE INC.8$140
E.R. Squibb & Sons, L.L.C.4$107
Otsuka America Pharmaceutical, Inc.5$98
Teva Pharmaceuticals USA, Inc.2$47
Almatica Pharma LLC2$33

Products named: INGREZZA, VRAYLAR, COBENFY, REXULTI, UZEDY, LOREEV XR, ABILIFY MAINTENA.

Industry payments across PA — which companies pay providers there.